RxDoctor Payments Data

Gulbin Antapli-Zeb

Physician Assistant · Patchogue, NYNPI 1831600881

Payments from drug & device makers

$3,373in general payments, 2019–2025

Across 203 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AbbVie$649
  • Lilly USA, LLC$292
  • Novo Nordisk$290
  • Ferring Pharmaceuticals Inc.$134
  • Nestle Healthcare Nutrition Inc.$133
  • plus $843 from 20 others

What the payments were for

  • Food & beverage$3,373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,373 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin25$109,568
MounjaroTirzepatide70$73,595
OzempicSemaglutide53$59,434
RybelsusSemaglutide41$51,430
JardianceEmpagliflozin36$37,370
LinzessLinaclotide41$28,216
WegovySemaglutide20$25,539
EliquisApixaban33$23,037
ViberziEluxadoline12$18,517
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$10,566
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,431
VascepaIcosapent Ethyl23$8,904
Breo ElliptaFluticasone/Vilanterol12$4,692
Mesalamine ErMesalamine25$4,085
Icosapent Ethyl11$3,545

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy$290$136,403114 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$1,032$109,56825 claims
Lilly USA, LLCMounjaro$292$73,59570 claims
AbbVieLinzess, Viberzi, Synthroid$649$47,61674 claims
PfizerEliquis$74$23,03733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Patchogue

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →